Susan C. Hicks

Clinical validation of a next-generation sequencing-based multi-cancer early detection “liquid biopsy” blood test in over 1,000 dogs using an independent testing set: The CANcer Detection in Dogs (CANDiD) study

Patrick C. Fiaux, D. Tsui, F. Marass, 2022, PloS one.

Next-generation sequencing-based liquid biopsy can be used for detection of residual disease and cancer recurrence monitoring in dogs

Patrick C. Fiaux, D. Grosu, K. Kruglyak, 2023, bioRxiv.

Clinical experience with next-generation sequencing-based liquid biopsy testing for cancer detection in dogs: a review of 1,500 consecutive clinical cases.

Patrick C. Fiaux, Maggie A. Marshall, F. Marass, 2023, Journal of the American Veterinary Medical Association.

Clinical validation of a blood-based liquid biopsy test integrating cell-free DNA quantification and next-generation sequencing for cancer screening in dogs.

D. Grosu, J. Tynan, Carlos A. Ruiz-Pérez, 2024, Journal of the American Veterinary Medical Association.